Metformin associated lactic acidosis (MALA): clinical profiling and management

Journal of Nephrology

Volumn 29, Issue 6, 2016, Pages 783-789

  Moioli, Alessandra ^a,b   Maresca, Barbara ^a,b   Manzione, Andrea ^a,b   Napoletano, Antonello Maria ^c   Coclite, Daniela ^c   Pirozzi, Nicola ^a,b   Punzo, Giorgio ^a,b   Menè, Paolo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Acute renal failure; Bicarbonate; Hemodialysis; Lactic acidosis; Metformin; Type 2 diabetes

Indexed keywords

ALKALI; ANTIDIABETIC AGENT; BICARBONATE; LACTIC ACID; METFORMIN;

ACIDEMIA; ACUTE KIDNEY FAILURE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DRUG ACCUMULATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MALE; METFORMIN ASSOCIATED LACTIC ACIDOSIS; MODERATE RENAL IMPAIRMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL REPLACEMENT THERAPY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEVERE RENAL IMPAIRMENT; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; URINE VOLUME; ACID BASE BALANCE; ACIDOSIS, LACTIC; CHEMICALLY INDUCED; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; ITALY; KIDNEY; MEDICAL RECORD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ACID-BASE EQUILIBRIUM; ACIDOSIS, LACTIC; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; MEDICAL RECORDS; METFORMIN; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; ROME; TREATMENT OUTCOME;

EID: 84992446867     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-016-0267-8     Document Type: Article

References (52)

1. Oulahiane A, Anaddam S, Ouleghzal H et al (2012) Diabetes management issues for patients with chronic kidney disease. Nephrol Ther 8:135–140. doi:10.1016/j.nephro.2011.07.410 (Epub 2011 Oct 20)
2. NICE (2009) Type 2 diabetes: the management of type 2 diabetes. NICE guideline CG87. http://www.nice.org.uk/guidance/cg87/chapter/guidance
3. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379. doi:10.2337/dc12-0413 (Epub 2012 Apr 19)
4. Lipska KJ, Bailey CJ, Inzucchi SE (2011) Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 34:1431–1437. doi:10.2337/dc10-2361
5. Nathan DM, Buse JB, Davidson MB (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A Consensus Statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721
6. (2014) Standards of medical care in diabetes. Diabetes Care 37 Suppl 1:S14–S80. doi:10.2337/dc14-S014
7. Viollet B, Guigas B, Sanz Garcia N et al (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 122:253–270. doi:10.1042/CS20110386
8. Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334:574–579
9. Duong JK, Kumar SS, Kirkpatrick CM et al (2013) Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet 52:373–384. doi:10.1007/s40262-013-0046-9
10. Vecchio S, Giampreti A, Petrolini VM et al (2014) Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila) 52:129–135. doi:10.3109/15563650.2013.860985 (Epub 2013 Nov 28)
11. Kajbaf F, Lalau JD (2014) Mortality rate in so-called “metformin-associated lactic acidosis”: a review of the data since the 1960s. Pharmacoepidemiol Drug Saf 23:1123–1127. doi:10.1002/pds.3689 (Epub 2014 Jul 31)
12. Pasquel FJ, Klein R, Adigweme A (2015) Metformin-associated lactic acidosis. Am J Me Sci 349:263–267. doi:10.1097/MAJ.0b013e3182a562b7
13. Salpeter SR, Greyber E, Pasternak GA et al (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. doi:10.1002/14651858.CD002967.pub3
14. Shaw JS, Wilmot RL, Kilpatrick ES (2007) Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet Med 24:1160–1163
15. Foretz M, Guigas B, Bertrand L et al (2014) Metformin: from mechanisms of action to therapies. Cell Metab 20:953–966. doi:10.1016/j.cmet.2014.09.018 (Epub 2014 Oct 30)
16. Sliwinska A, Drzewoski J (2015) Molecular action of metformin in hepatocytes: an updated insight. Curr Diabetes Rev 11:175–181
17. Pernicova I, Korbonits M (2014) Metformin—mode of action and clinicla implications for diabetes and cancer. Nat Rev Endocrinol 10:143–156. doi:10.1038/nrendo.2013.256 (Epub 2014 Jan 7)
18. Sulkin TV, Bosman D, Krentz AJ (1997) Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 20:925–928
19. Inzucchi SE, Lipska KJ, Mayo H et al (2014) Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 312:2668–2675. doi:10.1001/jama.2014.15298
20. Hung SC, Chang YK, Liu JS et al (2015) Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. Lancet Diabetes Endocrinol 3:605–614. doi:10.1016/S2213-8587(15)00123-0 (Epub 2015 Jun 17)
21. Makehei S, Sam R (2015) Does lactate account for all of the increase in anion gap in cases of metformin-induced lactic acidosis? Clin Exp Nephrol 19:1210–1211. doi:10.1007/s10157-015-1124-0 (Epub 2015 May 16)
22. Suh S (2015) Metformin-associated lactic acidosis. Endocrinol Metab (Seoul) 30:45–46. doi:10.3803/EnM.2015.30.1.45
23. Adam WR, O’Brien RC (2014) A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure. Diabet Med 31:1032–1038. doi:10.1111/dme.12515
24. Eppenga WL, Lalmohamed A, Geerts AF et al (2014) Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care 37:2218–2224. doi:10.2337/dc13-3023 (Epub 2014 May 19)
25. Heaf J (2014) Metformin in chronic kidney disease: time for a rethink. Perit Dial Int 34:353–357. doi:10.3747/pdi.2013.00344 (Epub 2014 Apr 7)
26. Lalau JD, Arnouts P, Sharif A (2015) Metformin and other antidiabetic agents in renal failure patients. Kidney Int 87:308–322. doi:10.1038/ki.2014.19 (Epub 2014 Mar 5)
27. Huang W, Castelino RL, Peterson GM (2014) Metformin usage in type 2 diabetes mellitus: Are safety guidelines adhered to? Intern Med J 44:266–272. doi:10.1111/imj.12369
28. Lu WR, Defilippi J, Braun A (2013) Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Ann Pharmacother 47:1488–1497. doi:10.1177/1060028013505428 (Epub 2013 Oct 10)
29. Sambol NC, Chiang J, Lin ET, Goodman AM et al (1995) Kidney function and age are both predictors of pharmacokinetics of metformin. J Clin Pharmacol 35:1094–1102
30. Emslie-Smith AM, Boyle DIR, Evans JMM et al (2001) Contraindications to metformin therapy in patients with type 2 diabetes—a population-based study of adherence to prescribing guidelines. Diabet Med 18:483–488
31. Scheen AJ (2015) Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment. Evid Based Med 20:115. doi:10.1136/ebmed-2015-110184 (Epub 2015 Mar 31)
32. Kim MJ, Han JY, Shin JY et al (2015) Metformin-associated lactic acidosis: predisposing factors and outcome. Endocrinol Metab (Seoul) 30:78–83. doi:10.3803/EnM.2015.30.1.78 (Epub 2014 Jul 18)
33. Lalau JD, Lacroix C, Compagnon P et al (1995) Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 18:779–784
34. Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Andréjak M, Lalau JD (2015) Unexpectedly long half-life of metformin elimination in cases of metformin accumulation. Diabet Med. doi:10.1111/dme.12959 (Epub ahead of print)
35. Juurlink DN, Roberts DM (2014) The enigma of metformin-associated lactic acidosis. Clin Toxicol (Phila) 52:85–87. doi:10.3109/15563650.2014.880174
36. Almirall J, Briculle M et al (2008) Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice. Nephrol Dial Transplant 23:2436–2438. doi:10.1093/ndt/gfn152 (Epub 2008 Apr 3)
37. McNamara K, Isbister GK (2015) Hyperlactataemia and clinical severity of acute metformin overdose. Intern Med J 45:402–408. doi:10.1111/imj.12713
38. Richy FF, Sabidó-Espin M, Guedes S, Corvino FA, Gottwald-Hostalek U (2014) Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care 37:2291–2295. doi:10.2337/dc14-0464 (Epub 2014 May 30)
39. Lalau JD, Kajbaf F (2014) Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels. Int J Endocrinol 2014:717198. doi:10.1155/2014/717198 (Epub 2014 Dec 17)
40. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2003) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 163:2594–2602
41. Kajbaf F, Arnouts P, de Broe M (2013) Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiol Drug Saf 22:1027–1035. doi:10.1002/pds.3501 (Epub 2013 Aug 19)
42. Scheen AJ, Paquot N (2013) Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab 39:179–190. doi:10.1016/j.diabet.2013.02.006 (Epub 2013 Mar 23)
43. Petrie MC, Boyle JG, McKay GA (2015) Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base. Diabet Med 32:981–982. doi:10.1111/dme.12709
44. Mathieu C (2015) Metformin-associated lactic acidosis: time to let it go? J Diabetes Complications. doi:10.1016/j.jdiacomp.2015.07.022 (Epub ahead of print)
45. Stanton RC (2015) Metformin use in type 2 diabetes mellitus with CKD: Is it time to liberalize dosing recommendations? Am J Kidney Dis 66:193–195. doi:10.1053/j.ajkd.2015.04.001 (Epub 2015 May 8)
46. Kajbaf F, Lalau JD (2013) The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis. BMC Pharmacol Toxicol 14:22. doi:10.1186/2050-6511-14-22
47. Kraut JA, Madias NE (2014) Lactic acidosis. N Engl J Med 371:2309–2319. doi:10.1056/NEJMra1309483
48. Velissaris D, Karamouzos V, Ktenopoulos N et al (2015) The use of sodium bicarbonate in the treatment of acidosis in sepsis: a literature update on a long term debate. Crit Care Res Pract 2015:605830. doi:10.1155/2015/605830 (Epub 2015 Jul 30)
49. Adeva-Andany M, López-Ojén M, Funcasta-Calderón R et al (2014) Comprehensive review on lactate metabolism in human health. Mitochondrion 17:76–100. doi:10.1016/j.mito.2014.05.007 (Epub 2014 Jun 12)
50. Calello DP, Liu KD, Wiegand TJ et al (2015) Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med 43:1716–1730. doi:10.1097/CCM.0000000000001002
51. Lebiedz P, Knickel L, Engelbertz C et al (2014) Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit. J Nephrol 27(1):73–80. doi:10.1007/s40620-013-0016-1 (Epub 2013 Dec 7)
52. Thongprayoon C, Cheungpasitporn W, Srivali N et al (2015) The impact of fluid balance on diagnosis, staging and prediction of mortality in critically ill patients with acute kidney injury. J Nephrol (Epub ahead of print) PMID: 26012379